SA
MRK icon

Strategic Advocates’s Merck MRK Stock Holding History

Strategic Advocates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,029
Closed -$109K – 479
2025
Q4 		$109K Buy
1,029
+15
+1% +$1.41K 0.03% 156
2025
Q3 		$85.1K Buy
+1,014
New +$83.5K 0.02% 172
2024
Q2 		– Sell
-1,743
Closed -$230K – 134
2024
Q1 		$230K Buy
+1,743
New +$215K 0.09% 113

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Strategic Advocates's MRK Position: Q1 2026 in Review

Strategic Advocates sold out of Merck (MRK) in Q1 2026, closing a stake of 1,029 shares — an estimated $109K sold.

Strategic Advocates first reported a position in MRK in Q1 2024 and held it in 3 quarters. The position peaked at $230K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Strategic Advocates reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 1,029 Merck shares in Q1 2026, an estimated $109K.
  • Strategic Advocates first reported a position in Merck in Q1 2024 and held it in 3 quarters.
  • Strategic Advocates's Merck position peaked at $230K in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.